Daniel S. Jonas - 25 Feb 2022 Form 4 Insider Report for CONMED Corp (CNMD)

Role
EVP Legal Affairs,Gen. Counsel
Signature
Daniel S. Jonas
Issuer symbol
CNMD
Transactions as of
25 Feb 2022
Net transactions value
-$531,328
Form type
4
Filing time
01 Mar 2022, 15:10:05 UTC
Previous filing
05 Jan 2022
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $39,380 +500 +4.1% $78.76 12,667 25 Feb 2022 Direct
transaction CNMD Common Stock Sale $75,015 -500 -3.9% $150.03 12,167 25 Feb 2022 Direct F1
transaction CNMD Common Stock Options Exercise $263,295 +3,343 +27% $78.76 15,510 25 Feb 2022 Direct
transaction CNMD Common Stock Sale $499,482 -3,343 -22% $149.41 12,167 25 Feb 2022 Direct F2
transaction CNMD Common Stock Options Exercise $121,624 +1,245 +10% $97.69 13,412 25 Feb 2022 Direct
transaction CNMD Common Stock Sale $186,750 -1,245 -9.3% $150.00 12,167 25 Feb 2022 Direct
transaction CNMD Common Stock Options Exercise $366,826 +3,755 +31% $97.69 15,922 25 Feb 2022 Direct
transaction CNMD Common Stock Sale $561,206 -3,755 -24% $149.46 12,167 25 Feb 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -500 -2% $0.000000 24,500 25 Feb 2022 Common Stock 500 $78.76 Direct F4
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -3,343 -14% $0.000000 21,157 25 Feb 2022 Common Stock 3,343 $78.76 Direct F4
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -1,245 -5% $0.000000 23,755 25 Feb 2022 Common Stock 1,245 $97.69 Direct F4
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -3,755 -16% $0.000000 20,000 25 Feb 2022 Common Stock 3,755 $97.69 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.16. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.40 to $149.63. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.40 to $149.56. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period